Chief Executive Officer, Patrik Dahlen Buys Immunovia Shares
LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) announced today that Immunovia’s Chief Executive Officer, Patrik Dahlen, has acquired Immunovia 15,000 shares for 2.5 MSEK on the open market and his total holding is now 45,000 shares. For more information, please contact: Julie Silber, Director of Investor Relations, Immunovia Email: julie.silber@immunovia.com Tel: +46 7 93 486 277 The information was submitted for publication, through the agency of the contact person set out above, at 17:30 CET on November 17, 2020. About ImmunoviaImmunovia AB is a diagnostic company